Position in JSPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,974
-$250,920 QoQ
Shares Held
14,192
-95.2% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 44 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JSPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. JSPR ranks #334 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in JSPR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,974 | 14,192 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $256,894 | 293,259 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $536,238 | 293,027 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $701,035 | 294,553 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,628,702 | 293,460 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,550,961 | 360,689 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,140,421 | 287,204 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,129,821 | 325,881 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,384,853 | 325,324 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,388,946 | 319,787 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,509,066 | 3,180,059 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,226,210 | 3,180,301 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,085,371 | 2,252,096 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,224,665 | 1,781,583 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $16 | 36 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||